tiprankstipranks
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market

Zenas BioPharma, Inc. (ZBIO) Financial Statements

Compare
64 Followers

Zenas BioPharma, Inc. Financial Overview

Zenas BioPharma, Inc.'s market cap is currently $323.04M. The company's EPS TTM is $; its P/E ratio is ―; Zenas BioPharma, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Income Statement
Total Revenue
Gross Profit$ 50.00M
Operating Income$ -37.15M
EBITDA$ -36.71M
Net Income$ -37.12M
Balance Sheet
Cash & Short-Term Investments$ ―
Total Assets$ 68.18M
Total Debt$ 813.00K
Net Debt$ -56.04M
Total Liabilities$ 43.81M
Stockholders' Equity$ ―
Cash Flow
Free Cash Flow$ -30.55M
Operating Cash Flow$ -30.53M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History

Zenas BioPharma, Inc. Debt to Assets

Zenas BioPharma, Inc. Cash Flow

Zenas BioPharma, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis